PALO ALTO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that company management will present a corporate overview at an upcoming investor conference.
Robert M. Myers, President of Jazz Pharmaceuticals, will speak at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18, 2009 at 2:15 p.m. EST at The St. Regis Hotel in New York City.
After the presentation, the slides may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. The slides will be available on the site for two weeks following the presentation.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information please see www.jazzpharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.
Willie Quinn, Executive Director, Corporate Development of Jazz Pharmaceuticals, Inc., investorinfo@jazzpharmaceuticals.com; or Karen L. Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both of BCC Partners for Jazz Pharmaceuticals, Inc.
